Literature DB >> 11432133

Should we continue oesophageal surgery in a district general hospital? A review of 200 consecutive cases.

G H Dickson1, R Waters, J Bull, V Kaul, J Sitzia.   

Abstract

A series of 200 oesophageal resections is presented. The results show that acceptable standards are obtainable in a district general hospital (DGH) thus favouring the suggestion that such services could be organised by 'networking' rather than centralisation. This avoids the disadvantages to many DGH patients which follow centralisation.

Entities:  

Mesh：

Year:  2001        PMID： 11432133      PMCID： PMC2503585     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


  16 in total

1.  Changing patterns and surgical results in adenocarcinoma of the oesophagus.

Authors:  P Thomas; C Doddoli; P Lienne; N Morati; X Thirion; L Garbe; R Giudicelli; P Fuentes
Journal:  Br J Surg       Date:  1997-01       Impact factor: 6.939

2.  Treatment of oesophageal carcinoma at a small rural hospital.

Authors:  P G Reasbeck
Journal:  J R Coll Surg Edinb       Date:  1998-10

3.  Left-sided subtotal oesophagectomy for carcinoma.

Authors:  H R Matthews; A Steel
Journal:  Br J Surg       Date:  1987-12       Impact factor: 6.939

4.  Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group.

Authors:  B P Wijnhoven; P D Siersema; W C Hop; H van Dekken; H W Tilanus
Journal:  Br J Surg       Date:  1999-04       Impact factor: 6.939

5.  Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial.

Authors:  M Goldminc; G Maddern; E Le Prise; B Meunier; J P Campion; B Launois
Journal:  Br J Surg       Date:  1993-03       Impact factor: 6.939

6.  Total thoracic esophagectomy for esophageal cancer.

Authors:  V A Anikin; K G McManus; A N Graham; J A McGuigan
Journal:  J Am Coll Surg       Date:  1997-12       Impact factor: 6.113

7.  Lymph node metastasis and lymphadenectomy for carcinoma in the gastric cardia: clinical experience.

Authors:  I Kodama; K Kofuji; S Yano; K Shinozaki; N Murakami; H Hori; J Takeda; K Shirouzu
Journal:  Int Surg       Date:  1998 Jul-Sep

8.  Oesophagogastrectomy for carcinoma of the oesophagus and cardia.

Authors:  J Rahamim; C W Cham
Journal:  Br J Surg       Date:  1993-10       Impact factor: 6.939

9.  Changes in the surgical management of esophageal cancer from 1970 to 1993.

Authors:  S G Swisher; K K Hunt; E C Holmes; M J Zinner; D W McFadden
Journal:  Am J Surg       Date:  1995-06       Impact factor: 2.565

10.  Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer.

Authors:  H Bartels; H J Stein; J R Siewert
Journal:  Br J Surg       Date:  1998-06       Impact factor: 6.939
View more
  5 in total

1.  Oesophageal cancer surgery.

Authors:  D C Britton
Journal:  J R Soc Med       Date:  2001-10       Impact factor: 5.344

2.  Should we continue oesophageal surgery in a district general hospital? A review of 200 consecutive cases.

Authors:  T C B Dehn; Iain Paterson; David Hunter; David Rae
Journal:  Ann R Coll Surg Engl       Date:  2002-07       Impact factor: 1.891

3.  Real-time outcome monitoring following oesophagectomy using cumulative sum techniques.

Authors:  Geoffrey Roberts; Cheuk-Bong Tang; Mike Harvey; Sritharan Kadirkamanathan
Journal:  World J Gastrointest Surg       Date:  2012-10-27

4.  Centralisation of oesophagogastric cancer services: can specialist units deliver?

Authors:  M J Forshaw; J A Gossage; J Stephens; D Strauss; A J Botha; S Atkinson; R C Mason
Journal:  Ann R Coll Surg Engl       Date:  2006-10       Impact factor: 1.891

5.  Prospective comparison of the perceived preoperative computed tomographic, endosonographic and histopathological stage of oesophageal cancer related to body mass indices.

Authors:  Christopher P Twine; S Ashley Roberts; Jonathan D Barry; Huw Oliphant; Matthew A Morgan; Guy R J Blackshaw; Wyn G Lewis
Journal:  Eur Radiol       Date:  2008-10-29       Impact factor: 5.315
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.